UniProtKB/Swiss-Prot Q9BXB1: Variant p.Ser215Gly

Leucine-rich repeat-containing G-protein coupled receptor 4
Gene: LGR4
Feedback?

Variant information Variant position:

215 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Serine (S) to Glycine (G) at position 215 (S215G, p.Ser215Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from small size and polar (S) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Polymorphism:

Genetic variations in LGR4 define the bone mineral density quantitative trait locus 17 (BMND17) [MIM:615311]. Variance in bone mineral density influences bone mass, contributes to size determination in the general population, and is a susceptibility factor for osteoporotic fractures. Additional information on the polymorphism described.
Other resources:

Links to websites of interest for the variant.

Variant rs2448010 [ dbSNP | Ensembl ]

Sequence information Variant position:

215 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

951 The length of the canonical sequence.
Location on the sequence:

FAFTNLSSLVVLHLHNNKIR S LSQHCFDGLDNLETLDLNYN The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         FAFTNLSSLVVLHLHNNKIRSLSQHCFDGLDNLETLDLNYN

Mouse                         FAFTNLSSLVVLHLHNNKIKSLSQHCFDGLDNLETLDLNYN

Rat                           FAFTNLSSLVVLHLHNNKIKSLSQHCFDGLDNLETLDLNYN

Bovine                        FAFTNLSSLVVLHLHNNKIKSLGQHCFDGLDNLETLDLNYN

Xenopus tropicalis            YAFSNLSSLVVLHLHNNKIRTLGPHCFHGLDNLEALDLNYN

Zebrafish                     NAFANLSSLVVLHLHNNRIQEIGKNCFNGLDNLETLDLNFN

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	25 – 951	Leucine-rich repeat-containing G-protein coupled receptor 4
Topological domain	25 – 544	Extracellular
Repeat	202 – 223	LRR 7
Glycosylation	199 – 199	N-linked (GlcNAc...) asparagine

Literature citations
Molecular characterization of a novel glycoprotein hormone G-protein-coupled receptor.
Loh E.D.; Broussard S.R.; Kolakowski L.F. Jr.;
Biochem. Biophys. Res. Commun. 282:757-764(2001)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1); VARIANTS GLY-215 AND SER-233;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.